Patents by Inventor Avram Scheiner

Avram Scheiner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210228873
    Abstract: A system for treating obstructive sleep apnea (OSA) is described. The system may include a locking device having a size and shape selected to couple to skin along a jaw of a patient. The locking device may be configured to receive at least one of a needle or an introducer for insertion into a tongue of the patient for lead placement of a lead for OSA treatment, and lock at least a portion of the at least one of the needle or introducer in place to reduce movement of the needle or introducer within the tongue.
    Type: Application
    Filed: January 24, 2020
    Publication date: July 29, 2021
    Inventors: Avram Scheiner, David C. Hacker
  • Publication number: 20210228866
    Abstract: A lead for delivering electrical stimulation therapy is described. The lead includes an elongated member defining a longitudinal axis, one or more electrodes disposed at a distal end of the elongated member, a plurality of collars located along the longitudinal axis, and one or more fixation members. At least one of the fixation members is a bow-like member having a first connection point to a first collar of the plurality of collars and a second connection point to a second collar of the plurality of collars. The distal end of the elongated member is configured for insertion in a tongue of a patient such that the one or more electrodes are implanted proximate to one or more motor points of a protrusor muscle within the tongue of the patient and the bow-like member of the one or more fixation members is implanted within tissue of the tongue.
    Type: Application
    Filed: January 24, 2020
    Publication date: July 29, 2021
    Inventors: Avram Scheiner, Patrick W. Kinzie, Randal C. Schulhauser, David C. Hacker
  • Publication number: 20210228234
    Abstract: A system for treatment of obstructive sleep apnea (OSA) is described. The system includes an introducer needle having an elongated body. The introducer needle is configured to create an opening in a tongue of a patient for implantation of a lead for treating OSA. One or more electrically conductive areas are located on the elongated body. A medical device is configured to deliver a stimulation signal via the introducer needle through the one or more electrically conductive areas to the tongue of the patient to stimulate one or more motor points of a protrusor muscle within the tongue of the patient.
    Type: Application
    Filed: January 24, 2020
    Publication date: July 29, 2021
    Inventors: Avram Scheiner, James Hissong
  • Publication number: 20210228871
    Abstract: Disclosed is a system for stimulation of a subject. The stimulation may be to provide therapy to treat the subject. Stimulation may be of selected muscle groups and/or portions.
    Type: Application
    Filed: January 24, 2020
    Publication date: July 29, 2021
    Inventors: Avram SCHEINER, James Britton Hissong, Rebecca J. Haag, Randal C. Schulhauser
  • Publication number: 20210153751
    Abstract: This disclosure is directed to devices, systems, and techniques for monitoring a patient condition. In some examples, a medical device system includes processing circuitry configured to determine a plurality of pulse transit time (PTT) intervals, determine, based on an accelerometer signal, a posture of a patient from a plurality of postures corresponding to each PTT interval of the plurality of PTT intervals, classify each PTT interval of the plurality of PTT intervals based on the respective posture of the patient corresponding to the respective PTT interval, and monitor, based on the classified plurality of PTT intervals, a patient condition.
    Type: Application
    Filed: November 21, 2019
    Publication date: May 27, 2021
    Inventors: Bruce D. Gunderson, Avram Scheiner
  • Publication number: 20200282219
    Abstract: An implantable neurostimulator (INS) and method of use, the INS including an electrical lead having formed thereon at least a pair of bi-polar electrodes, wherein the electrical lead is configured for placement of the pair of bi-polar electrodes proximate protrusor muscles of a patient, a pulse generator electrically connected to the electrical lead and configured to deliver electrical energy to the pair of bi-polar electrodes, the pulse generator having mounted therein a sensor and a control circuit, and the sensor is configured to generate signals representative of an orientation of the pulse generator and communicate the signals to the control circuit and the control circuit is configured to determine the orientation of the pulse generator and deliver electrical energy to the bi-polar electrodes when the determined orientation correlates to a pre-determined orientation.
    Type: Application
    Filed: January 24, 2020
    Publication date: September 10, 2020
    Inventors: Avram Scheiner, James Hissong
  • Publication number: 20200281522
    Abstract: A system and method of diagnosing sleep apnea including an implantable device with a sensor, a telemetry circuit and a memory, an external programmer in communication with the telemetry circuit and configured to receive data collected by the sensor and stored in the memory. The system and method include operation of a server, including a processor, in communication with the external programmer and storing an application including instructions that when executed by the processor executes steps of receiving the data collected by the sensor from the external programmer, analyzing the received data collected by the sensor, and transmitting to a remote computer an assessment of the received sensor data, wherein the assessment includes an evaluation of sleep apnea for the patient.
    Type: Application
    Filed: January 24, 2020
    Publication date: September 10, 2020
    Inventors: Avram Scheiner, Patrick W. Kinzie, Randal Schulhauser
  • Publication number: 20200281763
    Abstract: A medical device system and method are disclosed for treating obstructive sleep apnea. The system includes a pulse generator and a medical electrical lead including multiple electrodes carried by a distal portion of an elongated lead body. The method includes advancing the distal portion within protrusor muscle tissue below the oral cavity and delivering electrical stimulation pulses via the electrodes to sustain a protruded state throughout a delivery time period to sustain a protruded state of a patient's tongue throughout the therapy delivery time period. The therapy delivery time period may span multiple respiration cycles.
    Type: Application
    Filed: March 6, 2020
    Publication date: September 10, 2020
    Inventor: Avram SCHEINER
  • Publication number: 20200282215
    Abstract: A system and method of assessing therapy of an implantable neurostimulator (INS), the INS including a lead having at least one pair of bi-polar electrodes, and a pulse generator in electrical communication with the bi-polar electrodes, the pulse generator including a sensor, a memory, a control circuit, and a telemetry circuit. The system and method includes an external programmer in communication with the INS via the telemetry circuit, a server in communication with the external programmer and including thereon an application configured to receive sensor data from the INS from the external programmer and assess a quality of the sleep of a patient in which the INS is implanted based on the received sensor data, and a remote computer in communication with the server and configured to present an assessment of the quality of sleep of the patient.
    Type: Application
    Filed: January 24, 2020
    Publication date: September 10, 2020
    Inventors: Avram Scheiner, Randal Schulhauser, James Hissong, Erik Scott, Rebecca Haag
  • Publication number: 20190307361
    Abstract: Systems and methods for evaluating neuromodulation via hemodynamic responses are disclosed herein. A system configured in accordance with embodiments of the present technology can include, for example, a neuromodulation catheter comprising an elongated shaft having a distal portion, and a plurality of electrodes spaced along a distal portion. The system can further include a controller communicatively coupled to the electrodes. The controller can be configured to apply first and second stimuli at and/or proximate to a target site within a blood vessel before and after delivering neuromodulation energy to the target site, and detect, via at least one of the electrodes, vessel impedance resulting from the first and second stimuli to determine a baseline impedance and a post-neuromodulation impedance. The controller can further be configured to assess the efficacy of the neuromodulation based, at least in part, on a comparison of the baseline impedance and the post-neuromodulation impedance.
    Type: Application
    Filed: June 25, 2019
    Publication date: October 10, 2019
    Inventors: Douglas Hettrick, Avram Scheiner
  • Patent number: 10368775
    Abstract: Systems and methods for evaluating neuromodulation via hemodynamic responses are disclosed herein. A system configured in accordance with embodiments of the present technology can include, for example, a neuromodulation catheter comprising an elongated shaft having a distal portion, and a plurality of electrodes spaced along a distal portion. The system can further include a controller communicatively coupled to the electrodes. The controller can be configured to apply first and second stimuli at and/or proximate to a target site within a blood vessel before and after delivering neuromodulation energy to the target site, and detect, via at least one of the electrodes, vessel impedance resulting from the first and second stimuli to determine a baseline impedance and a post-neuromodulation impedance. The controller can further be configured to assess the efficacy of the neuromodulation based, at least in part, on a comparison of the baseline impedance and the post-neuromodulation impedance.
    Type: Grant
    Filed: October 1, 2015
    Date of Patent: August 6, 2019
    Assignee: Medtronic Ardian Luxembourg S.a.r.l.
    Inventors: Douglas A. Hettrick, Avram Scheiner
  • Publication number: 20190117967
    Abstract: A removable oral device is disclosed. The removable oral device comprises a mounting retainer configured to align with a set of teeth. An electrical stimulator is coupled to the mounting retainer. A single lead is employed that has a first and a second end and lacking a mechanical connection to the mounting retainer. A first and a second electrode are positioned along the single lead. The lead is disposed perpendicular to a longitudinal axis of a patient's tongue such that the first electrode is proximate a first hypoglossal nerve and the second electrode is proximate a second hypoglossal nerve.
    Type: Application
    Filed: December 20, 2018
    Publication date: April 25, 2019
    Inventor: Avram Scheiner
  • Patent number: 10195428
    Abstract: A removable oral device is disclosed. The removable oral device comprises a mounting retainer configured to align with a set of teeth. An electrical stimulator is coupled to the mounting retainer. A single lead is employed that has a first and a second end and lacking a mechanical connection to the mounting retainer. A first and a second electrode are positioned along the single lead. The lead is disposed perpendicular to a longitudinal axis of a patient's tongue such that the first electrode is proximate a first hypoglossal nerve and the second electrode is proximate a second hypoglossal nerve.
    Type: Grant
    Filed: September 28, 2016
    Date of Patent: February 5, 2019
    Assignee: Medtronic, Inc.
    Inventor: Avram Scheiner
  • Patent number: 9861817
    Abstract: Medical devices and methods for providing breathing therapy (e.g., for treating heart failure, hypertension, etc.) may determine at least the inspiration phase of one or more breathing cycles based on the monitored physiological parameters and control delivery of a plurality of breathing therapy sessions (e.g., each of the breathing therapy sessions may be provided during a defined time period). Further, each of the plurality of breathing therapy sessions may include delivering stimulation after the start of the inspiration phase of each of a plurality of breathing cycles to prolong diaphragm contraction during the breathing cycle.
    Type: Grant
    Filed: August 8, 2013
    Date of Patent: January 9, 2018
    Assignee: Medtronic, Inc.
    Inventors: Yong K Cho, Shaileshkumar V Musley, Avram Scheiner
  • Publication number: 20170087360
    Abstract: A removable oral device is disclosed. The removable oral device comprises a mounting retainer configured to align with a set of teeth. An electrical stimulator is coupled to the mounting retainer. A single lead is employed that has a first and a second end and lacking a mechanical connection to the mounting retainer. A first and a second electrode are positioned along the single lead. The lead is disposed perpendicular to a longitudinal axis of a patient's tongue such that the first electrode is proximate a first hypoglossal nerve and the second electrode is proximate a second hypoglossal nerve.
    Type: Application
    Filed: September 28, 2016
    Publication date: March 30, 2017
    Inventor: Avram Scheiner
  • Patent number: 9572982
    Abstract: This disclosure is directed to extra, intra, and transvascular medical lead placement techniques for arranging medical leads and electrical stimulation and/or sensing electrodes proximate nerve tissue within a patient.
    Type: Grant
    Filed: April 30, 2009
    Date of Patent: February 21, 2017
    Assignee: Medtronic, Inc.
    Inventors: John E. Burnes, Kenneth C. Gardeski, Ruth N. Klepfer, Patrick E. Macaulay, Mary M. Morris, Avram Scheiner
  • Patent number: 9561369
    Abstract: This disclosure is directed to extra, intra, and transvascular medical lead placement techniques for arranging medical leads and electrical stimulation and/or sensing electrodes proximate nerve tissue within a patient.
    Type: Grant
    Filed: November 20, 2012
    Date of Patent: February 7, 2017
    Assignee: Medtronic, Inc.
    Inventors: John E Burnes, Mary M Morris, Matthew David Bonner, Michael R. S. Hill, Avram Scheiner, Ruth N Klepfer
  • Patent number: 9370654
    Abstract: An implantable medical device and associated method deliver a therapy to an autonomic nerve. The therapy delivery includes delivering therapeutic low frequency (LF) electrical stimulation pulses to the autonomic nerve and delivering a high frequency electrical signal to the autonomic nerve during the LF frequency stimulation pulse delivery. The high frequency stimulation signal blocks activation of autonomic nerve fibers innervating a non-targeted tissue during the therapeutic LF stimulation pulse delivery.
    Type: Grant
    Filed: January 27, 2009
    Date of Patent: June 21, 2016
    Assignee: Medtronic, Inc.
    Inventors: Avram Scheiner, David E. Euler
  • Publication number: 20160166831
    Abstract: Medical devices and methods for providing breathing therapy (e.g., for treating heart failure, hypertension, etc.) may determine at least the inspiration phase of one or more breathing cycles based on the monitored physiological parameters and control delivery of a plurality of breathing therapy sessions (e.g., each of the breathing therapy sessions may be provided during a defined time period). Further, each of the plurality of breathing therapy sessions may include delivering stimulation after the start of the inspiration phase of each of a plurality of breathing cycles to prolong diaphragm contraction during the breathing cycle.
    Type: Application
    Filed: August 8, 2013
    Publication date: June 16, 2016
    Inventors: Yong K. Cho, Shaileshkumar V. Musley, Avram Scheiner
  • Publication number: 20160095535
    Abstract: Systems and methods for evaluating neuromodulation via hemodynamic responses are disclosed herein. A system configured in accordance with embodiments of the present technology can include, for example, a neuromodulation catheter comprising an elongated shaft having a distal portion, and a plurality of electrodes spaced along a distal portion. The system can further include a controller communicatively coupled to the electrodes. The controller can be configured to apply first and second stimuli at and/or proximate to a target site within a blood vessel before and after delivering neuromodulation energy to the target site, and detect, via at least one of the electrodes, vessel impedance resulting from the first and second stimuli to determine a baseline impedance and a post-neuromodulation impedance. The controller can further be configured to assess the efficacy of the neuromodulation based, at least in part, on a comparison of the baseline impedance and the post-neuromodulation impedance.
    Type: Application
    Filed: October 1, 2015
    Publication date: April 7, 2016
    Inventors: Douglas A. Hettrick, Avram Scheiner